Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention

Journal of Proteomics

Volumn 75, Issue 4, 2012, Pages 1330-1342

  Bu, Qian ^a   Yang, Yanzhu ^a   Yan, Guangyan ^a   Hu, Zhengtao ^a   Hu, Chunyan ^a   Duan, Jiachuan ^a   Lv, Lei ^a   Zhou, Jiaqing ^a   Zhao, Jinxuan ^a   Shao, Xue ^a   Deng, Yi ^a   Li, Yan ^a   Li, Hongyu ^a   Zhu, Ruiming ^a   Zhao, Yinglan ^a   Cen, Xiaobo ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Morphine; Nucleus accumbens; Primate; Proteomics; Synucleins

Indexed keywords

ALPHA ACTIN; ALPHA SYNUCLEIN; ALPHA TROPOMYOSIN; BETA SYNUCLEIN; CALMODULIN; CLONIDINE; CYTOSKELETON PROTEIN; DIMETHYLARGININASE; ELONGATION FACTOR 1BETA; ELONGATION FACTOR TU; ENDOPHILIN; ENDOPLASMIC RETICULUM PROTEIN 29; FUMARYLACETOACETASE; GAMMA SYNUCLEIN; HEAT SHOCK PROTEIN 70; MALATE DEHYDROGENASE; METHADONE; NEURON SPECIFIC NUCLEAR PROTEIN; ORNITHINE OXOACID AMINOTRANSFERASE; PEPTIDES AND PROTEINS; PEROXIREDOXIN 2; PROTEASOME; PROTEIN SERINE THREONINE KINASE; PYRIDOXAL KINASE; PYRUVATE DEHYDROGENASE; STATHMIN; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN I; TROPOMODULIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOSOL; ELECTROPHORESIS; MALE; MASS SPECTROMETRY; METABOLISM; MORPHINE ADDICTION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; RHESUS MONKEY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CYTOSOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; MACACA MULATTA; MALE; MASS SPECTROMETRY; MORPHINE; MORPHINE DEPENDENCE; NUCLEUS ACCUMBENS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTANCE WITHDRAWAL SYNDROME;

MACACA MULATTA; PRIMATES;

EID: 84855906864     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.11.008     Document Type: Article

References (53)

1. Cami J., Farre M. Drug addiction. N Engl J Med 2003, 349:975-986.
2. Koob G.F. Neurobiology of addiction. Focus 2011, 9:55.
3. Tannu N., Mash D., Hemby S. Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry 2006, 12:55-73.
4. Chen X.L., Lu G., Gong Y.X., Zhao L.C., et al. Expression changes of hippocampal energy metabolism enzymes contribute to behavioural abnormalities during chronic morphine treatment. Cell Res 2007, 17:689-700.
5. Tannu N., Howell L., Hemby S. Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration. Mol Psychiatry 2008, 15:185-203.
6. Li K.W., Jimenez C.R., van der Schors R.C., Hornshaw M.P., et al. Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 2006, 6:2003-2008.
7. Bierczynska-Krzysik A., Pradeep J.J.P., Silberring J., Kotlinska J., et al. Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int J Mol Med 2006, 18:775.
8. Yang L., Sun Z.S., Zhu Y. Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference. J Proteome Res 2007, 6:2239-2247.
9. Lin X.J., Wang Q.S., Cheng Y., Ji J., Yu L.C. Changes of protein expression profiles in the amygdala during the process of morphine-induced conditioned place preference in rats. Behav Brain Res 2011.
10. O'Brien S.J., Menotti-Raymond M., Murphy W.J., Nash W.G., et al. The promise of comparative genomics in mammals. Science 1999, 286:458.
11. Gibbs R.A., Rogers J., Katze M.G., Bumgarner R., et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science 2007, 316:222.
12. Capitanio J.P., Emborg M.E. Contributions of non-human primates to neuroscience research. Lancet 2008, 371:1126-1135.
13. Stotts A.L., Dodrill C.L., Kosten T.R. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother 2009, 10:1727-1740.
14. Mattick, R., Breen, C., Kimber, J., Davoli, M., Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane database of systematic reviews (Online) 2002:CD002209.
15. Gowing, L., Farrell, M., Ali, R., White, J., Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane database of systematic reviews (Online) 2003:CD002024.
16. Gowing L.R., Farrell M., Ali R.L., White J.M. α2-Adrenergic agonists in opioid withdrawal. Addiction 2002, 97:49-58.
17. Schulteis G., Stinus L., Risbrough V.B., Koob G.F. Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats. Neuropsychopharmacology 1998, 19:406-416.
18. Yan J.X., Wait R., Berkelman T., Harry R.A., et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21:3666-3672.
19. Chen S., Zhai H., Cui Y., Shi J. Clonidine attenuates morphine withdrawal and subsequent drug sensitization in rhesus monkeys. Acta Pharmacol Sin 2007, 28:473-483.
20. Whistler L.H.J.L. The biochemical analysis of methadone modulation on morphine-induced tolerance and dependence in the rat brain. Pharmacology 2007, 79:193-202.
21. Gerra G., Marcato A., Caccavari R., Fontanesi B., et al. Clonidine and opiate receptor antagonists in the treatment of heroin addiction. J Subst Abuse Treat 1995, 12:35-41.
22. Perez-Alvarez S., Cuenca-Lopez M.D., de Mera R.M., Puerta E., et al. Methadone induces necrotic-like cell death in SH-SY5Y cells by an impairment of mitochondrial ATP synthesis. Biochim Biophys Acta 1802, 2010:1036-1047.
23. Kong K.Y., Kedes L. Leucine 135 of tropomodulin-1 regulates its association with tropomyosin, its cellular localization, and the integrity of sarcomeres. J Biol Chem 2006, 281:9589.
24. Kostyukova A.S., Rapp B.A., Choy A., Greenfield N.J., Hitchcock-DeGregori S.E. Structural requirements of tropomodulin for tropomyosin binding and actin filament capping. Biochemistry 2005, 44:4905-4910.
25. Cox P.R., Fowler V., Xu B., Sweatt J.D., et al. Mice lacking tropomodulin-2 show enhanced long-term potentiation, hyperactivity, and deficits in learning and memory. Mol Cell Neurosci 2003, 23:1-12.
26. Fang J., Nakamura T., Cho D.H., Gu Z., Lipton S.A. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease. Proc Natl Acad Sci 2007, 104:18742.
27. Rhee S.G., Chae H.Z., Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005, 38:1543-1552.
28. Yim M.B., Chae H.Z., Rhee S.G., Chock P.B., Stadtman E.R. On the protective mechanism of the thiol-specific antioxidant enzyme against the oxidative damage of biomacromolecules. J Biol Chem 1994, 269:1621.
29. Kim H., Lee T.H., Park E.S., Suh J.M., et al. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 2000, 275:18266.
30. Dietrich J.B., Mangeol A., Revel M.O., Burgun C., et al. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 2005, 48:965-974.
31. Macedo D.S., Vasconcelos S.M.M., Santos R.S., Aguiar L.M.V., et al. Cocaine alters catalase activity in prefrontal cortex and striatum of mice. Neurosci Lett 2005, 387:53-56.
32. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res/Rev Mutat Res 2000, 463:247-283.
33. Madden L.A., Sandström M.E., Lovell R.J., McNaughton L. Inducible heat shock protein 70 and its role in preconditioning and exercise. Amino acids 2008, 34:511-516.
34. Auluck P.K., Chan H., Trojanowski J.Q., Lee V.M.Y., Bonini N.M. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 2002, 295:865.
35. Auluck P.K., Meulener M.C., Bonini N.M. Mechanisms of suppression of α-synuclein neurotoxicity by geldanamycin in Drosophila. J Biol Chem 2005, 280:2873.
36. Klucken J., Shin Y., Masliah E., Hyman B.T., McLean P.J. Hsp70 reduces α-synuclein aggregation and toxicity. J Biol Chem 2004, 279:25497.
37. Hashimoto M., Hsu L.J., Xia Y., Takeda A., et al. Oxidative stress induces amyloid-like aggregate formation of NACP/[alpha]-synuclein in vitro. Neuroreport 1999, 10:717.
38. Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., et al. α-Synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 2000, 157:401-410.
39. Fan G.H., Wang L.Z., Qiu H.C., Ma L., Pei G. Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol Pharmacol 1999, 56:39.
40. Nehmad R., Nadler H., Simantov R. Effects of acute and chronic morphine treatment of calmodulin activity of rat brain. Mol Pharmacol 1982, 22:389.
41. Liedtke W., Leman E.E., Fyffe R.E.W., Raine C.S., Schubart U.K. Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. Am J Pathol 2002, 160:469.
42. Beyer K. Mechanistic aspects of Parkinson's disease: α-synuclein and the biomembrane. Cell Biochem Biophys 2007, 47:285-299.
43. Masliah E., Rockenstein E., Veinbergs I., Mallory M., et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 2000, 287:1265.
44. Feany M.B., Bender W.W. A Drosophila model of Parkinson's disease. Nature 2000, 404:394-398.
45. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001, 2:119-128.
46. Perez R.G., Waymire J.C., Lin E., Liu J.J., et al. A role for α-synuclein in the regulation of dopamine biosynthesis. J Neurosci 2002, 22:3090.
47. Yavich L., Tanila H., Vepsäläinen S., Jakala P. Role of α-synuclein in presynaptic dopamine recruitment. J Neurosci 2004, 24:11165.
48. Martinez J., Moeller I., Erdjument-Bromage H., Tempst P., Lauring B. Parkinson's disease-associated α-synuclein is a calmodulin substrate. J Biol Chem 2003, 278:17379.
49. Hashimoto M., Rockenstein E., Mante M., Mallory M., Masliah E. Beta-synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor. Neuron 2001, 32:213.
50. Mash D.C., Adi N., Duque L., Pablo J., et al. Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug Alcohol Depend 2008, 94:246-250.
51. Bönsch D., Lederer T., Reulbach U., Hothorn T., et al. Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence. Hum Mol Genet 2005, 14:967.
52. Bönsch D., Greifenberg V., Bayerlein K., Biermann T., et al. α-Synuclein protein levels are increased in alcoholic patients and are linked to craving. Alcohol Clin Exp Res 2005, 29:763-765.
53. Walker S.J., Grant K.A. Peripheral blood alpha-synuclein mRNA levels are elevated in cynomolgus monkeys that chronically self-administer ethanol. Alcohol 2006, 38:1-4.